Navigation Links
MDS Reports First Quarter 2008 Results
Date:3/6/2008

Net Revenues up 23%, Adjusted EBITDA up 33%

TORONTO, March 6 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported its first quarter 2008 results. For the quarter, MDS reported net revenues of $296 million, net income of $17 million and earnings per share from continuing operations of $0.14. Adjusted EBITDA rose to $40 million, up from $30 million in the prior year. Adjusted earnings per share were $0.05, down from $0.07 in the prior year. This solid start to 2008 is primarily driven by improvements at MDS Pharma Services and MDS Analytical Technologies, partially offset by challenges at MDS Nordion.

Quarterly Highlights

- Delivered $296 million in net revenues, up 23% from $241 million in

the prior year.

- Increased adjusted EBITDA to $40 million, up 33% from $30 million in

the prior year.

- Reported adjusted earnings per share of $0.05, down from $0.07 in the

prior year impacted by $0.08 of intangible amortization from the

Molecular Devices acquisition.

- MDS Pharma Services delivered $146 million in total revenues and

$6 million in adjusted EBITDA, up from $1 million in the prior year

with new business wins at $177 million up 32% over the prior quarter.

- MDS Nordion delivered $60 million in revenues, down 10% in the

quarter impacted by a medical isotope supply disruption and light

cobalt shipments.

- MDS Analytical Technologies delivered $116 million in revenues and

$27 million in adjusted EBITDA with the highest quarterly revenue in

Molecular Devices history.

- MDS repurchased and cancelled 252,000 Common shares for $5 million

under its Normal Course Issuer Bid.

"We are off to a solid start in the first quarter with double-digit growth in both net revenue
'/>"/>

SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. American Oriental Bioengineering Reports Fourth Quarter and Full Year 2007 Financial Results
2. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
3. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
4. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
5. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
6. Endocare Reports 2007 Annual and Fourth Quarter Financial Results
7. Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Womens Health Watch
8. CardiacQA Surpasses 20,000 Client Generated Nuclear Cardiology Reports
9. Sunrise Reports Preliminary Selected Financial and Operating Data for Fourth-Quarter 2007
10. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
11. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... PITTSBURGH, PA (PRWEB) , ... August 29, 2015 ... ... 1996," said one of two inventors from Miller Place, N.Y. "I specialize in ... pain and discomfort. In addition, it can be used for additional muscle dysfunction ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor ... (which astronomically, officially ends on September 22nd this year). For IT security personnel, it ... linger on which could prove far more costly than a simple headache. , Joe ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences announced today ... and Arterosil HP, and that all claims and counterclaims have been irrevocably dismissed. ... (VHS) in the United States District Court for the Southern District of Texas ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce Investment Commissioner ... they are applying for, they are unable to pass the initial drug test and ... testing policies in order to be able to hire long-term, skilled talent. (1) Will ...
(Date:8/28/2015)... , ... August 28, 2015 , ... As reported ... Merz, received FDA clearance for results that last for two years, the longest ... news for patients who are looking for a long-lasting, effective solution for their cellulite, ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... DC (February 1, 2010) Through the use of ... how to teach their child to communicate and improve ... 2010 issue of The Journal of Positive Behavior ... and SAGE)., Family members play a central role in ...
... blue skies and majestic mountains provided a scenic ... the most promising technologies on the horizonnanomedicine, or ... dedicated to constructing microscopic probes and biomechanical devices. ... academic, government and industry experts from across a ...
... may someday improve prevention efforts , MONDAY, Feb. 1 (HealthDay ... a pregnant mouse leads to changes inside the uterus that ... fetus. , The findings, published online in the ... to prevent and treat premature birth, the study,s senior investigator, ...
... ... you transform the way employees engage inside and outside of the workplace. , ... Milwaukee, Wisc. (PRWEB) February 1, 2010 -- ... the Corporate and Personal Brand,” hosted by Loyola University in Chicago. The hands-on ...
... were more likely to delay having sex, , , MONDAY, ... education classes were more likely to delay having sex, a ... 6th- and 7th-grade students, ranging in age from 10 to ... held on Saturdays at four Philadelphia public schools that draw ...
... and memory skills after 12 weeks of treatment, researchers ... antidepressants after a stroke may help repair the damaged ... , Little has been shown to help the brain ... after initial stroke treatment. But a University of Iowa ...
Cached Medicine News:Health News:Distance education for parents of children with autism found effective 2Health News:Summit examines vast applications of nanomedicine 2Health News:Summit examines vast applications of nanomedicine 3Health News:7Summits to Present at Soho Seminars 'Alignment of Personal and Corporate Brands' 2Health News:Abstinence-Only Classes Reduced Sexual Activity, Study Found 2Health News:Abstinence-Only Classes Reduced Sexual Activity, Study Found 3Health News:Antidepressants After Stroke May Boost Mental Ability 2Health News:Antidepressants After Stroke May Boost Mental Ability 3
(Date:8/28/2015)... Denmark and ATLANTA , August ... the US Food and Drug Administration (FDA) cleared the MagVita ... in adult patients who have failed to receive satisfactory improvement ... a non-invasive technique for stimulating neural tissue in the part ... Disorder. The procedure has been proven safe and effective and ...
(Date:8/28/2015)... y LONDRES, 28 de agosto de 2015 ... anunció hoy su participación en el  Congreso de ... soluciones cardiológicas más recientes y novedosas, entre ellas ... conectan a las personas y la tecnología con ... a diagnosticar, guiar los tratamientos y permitir atención ...
(Date:8/27/2015)...  A recent study by Feucht et al, ... Arthrosurface HemiCAP® Wave implant, which is based on ... implant for isolated patellofemoral disease. While both implant ... scores, none of the patients in the "inlay" ... of the patients in the "onlay" group, showed ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... SAN MARINO, Calif. , July 6 ... of targeted genetic medicine, received a notice of allowance ... leading tumor-targeted gene delivery platform. The issuance of this ... follows on the heels of two major patent issuances ...
... N.J. , July 6 Nephros, Inc. (OTC Bulletin ... for therapeutic applications, infection control, and water purification, today reported that ... a standard component of its MRO portable reverse osmosis water treatment ... , ...
Cached Medicine Technology:Small, Smart, Stealth Nanoparticles Seek-and-Destroy Metastatic Cancers, as Epeius Biotechnologies Advances its Intellectual Property Estate With Additional U.S. Patents 2Small, Smart, Stealth Nanoparticles Seek-and-Destroy Metastatic Cancers, as Epeius Biotechnologies Advances its Intellectual Property Estate With Additional U.S. Patents 3Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 2Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 3Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 4Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 5
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
The TBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of total bilirubin in serum and plasma...
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
Medicine Products: